MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
50 hedge funds and large institutions have $39.2M invested in Merrimack Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
50
Holding in Top 10
1
Calls
$232K
Puts
–
Top Buyers
| 1 | +$3.92M | |
| 2 | +$2.87M | |
| 3 | +$1.21M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$920K |
| 5 |
2L
22NW LP
Seattle,
Washington
|
+$905K |
Top Sellers
| 1 | -$529K | |
| 2 | -$347K | |
| 3 | -$333K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$252K |
| 5 |
Goldman Sachs
New York
|
-$184K |